The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screening failure in clinical trials for patients with head and neck squamous cell carcinoma: A retrospective analysis.
 
Pablo Jiménez Labaig
Research Funding - Merck
Travel, Accommodations, Expenses - Merck; Novartis
 
Sandra Llop
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Merck; MSD
 
Antonio Rullan
No Relationships to Disclose
 
Ben O'Leary
Consulting or Advisory Role - Merck; Oliver Wyman
Speakers' Bureau - Merck
Research Funding - Pfizer
 
Kate Newbold
Speakers' Bureau - Eisai
 
Kee Howe Wong
No Relationships to Disclose
 
Shreerang Bhide
No Relationships to Disclose
 
Christopher Nutting
No Relationships to Disclose
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)